ZenzeTech

WHAT WE DO

Digital Biomarkers

For better understanding, treatment and diagnosis of neurological diseases

We are developing a solution for continuous home-monitoring of people with neurological diseases’ gait symptoms with non-invasive, connected insoles that give objective knowledge of the treatment’s efficacy, enabling neurologists to change it accordingly

THE MISsION

Helping people with neurological
diseases to a better quality of life

More than 100 MILLION PEOPLE LIVE WITH A NEUROLOGICAL DISEASE and experience gait difficulties and higher risk of falling. It has severe consequences for their QUALITY OF LIFE and presents a large economic impact on people and society related to hospitalisations, rehabilitation, homecare, and nursing homes. First, we target Parkinson’s Disease

THE PROBLEM

MAJOR CHALLENGE FOR PARKINSON'S PATIENTS

Parkinson’s patients typically have a 20-minute consultation every 6 months where they describe their course of disease to their neurologist. Based on that, the neurologist will decide on the medical treatment. This is challenging due to; the patients’ abilities to recollect 6 months of various symptoms, the fact that the symptoms change over time, and not two patients having the same course of disease or response to medication. This has severe consequences for patients, their families and society, with our target group experiencing:

Reduced mobility

independence and quality of life

Patients falling 20.8 times

per year and 4 times more in risk of hip-fractures

€19,300 extra cost

/year/patient in home care, nursing homes and hospitalisations

THE SOLUTION

Digital biomarkers

Targeting

Parkinson's Disease,
Next - Contact us for deeper insights

Zolemates - connected insoles with

pressure sensors, IMU, automatic data transfer and wireless charging

Data as digital biomarkers

Disease specific,
objective knowledge,
aI driven

app for neurologists and patients

digital diary of disease,
dialogue tool

THE SOLUTION

Connected Insoles

Conncected insoles with sensors for home-monitoring of gait in people with neurological diseases.

Patient story

Meet a Parkinson's patient

Parkinson’s patient with reduced mobility and independence 

I didn´t want to go outside because I was afraid of falling.
Parkinson´s has meant a huge decrease in life quality for me.

QUOTES

WHAT OTHERS SAY ABOUT US

Thomas R. Lund MedTech Investor

The idea of an insole providing data is good, it is a simple solution for the patient and neurologist to understand. ZenzeTech is addressing a big problem and therefor a big market.

Trine Hørmann Thomsen Post.doc, Movement Disorder Clinic, Rigshospitalet

The insoles can be a tremendous help since we get continuous patient data, which a clinician can use for making medical decisions […] It is all about constantly regulating the balance of the medical treatment, which has huge effect on this patient group […] I think this makes perfect sense and I cannot see how we can do without it.

Helle Monrad-Gylling DeepTech and Impact Investor

It is very important for me to trust the team. Christian and Magdalena possess a high degree of credibility, are transparent and honest which creates trust while they have the competencies to succeed.

Jesper Kihl Life Science Investor

Two key elements came into play when I invested in ZenzeTech – team and technology trends. I was impressed by the team behind ZenzeTech, they appeared trustworthy, calm, and composed with a good vision.

Merete Karlsborg Head Neurologist, Bispebjerg Hospital

I think it is a very good idea since it is exactly gait that you are measuring […] the hospital is an artificial environment, but we would like a picture of how it is going at home.

SELECTED PARTNERs

The idea of an insole providing data is good, it is a simple solution for the patient and neurologist to understand. ZenzeTech is addressing a big problem and therefor a big market. 

Thomas R. Lund

MedTech Investor

LATEST NEWS

HELLO!

MEET THE TEAM

LET´S TALK!

WANT TO COLLABORATE?